Keyword: Johnson & Johnson

News

Industry and Universities Combine to Create Apollo Therapeutics Fund

28.01.2016 - Three major drugs companies have joined forces with three leading UK universities to translate ground-breaking academic science into new medicines for a broad range of diseases...

News

GAVI and US Merck Link on Ebola Vaccine

27.01.2016 - Geneva, Switzerland-based GAVI (Global Alliance for Vaccines and Immunization), a public-private partnership, and Merck Sharp & Dohme (MSD), known in the US as Merck & Co, have...

News

J&J to cut 3,000 jobs in Medical Devices

20.01.2016 - US healthcare giant Johnson & Johnson has announced it will eliminate about 3,000 jobs in its medical devices division, or about 4-6% of the unit’s global workforce. The move is...

News

KPMG Expects 2016 to become Another Record Year for M&A in the Pharmaceutical Industry

12.01.2016 - Globally, mergers and acquisitions at a value of USD 372 billion were recorded in the chemical and pharmaceutical sector in 2015. This amounts to an increase of 74% compared with...

News

J&J and enGene to Collaborate on IBD

16.10.2015 - Canada’s enGne, a gene therapy company focused on development of therapeutics using its proprietary “Gene Pill”, and Janssen Biotech, one of the Janssen Pharmaceutical Companies of...

News

Johnson & Johnson in Share Buyback

14.10.2015 - US drugmaker Johnson & Johnson (J&J), the country’s largest healthcare company, in particular in the consumer segment, has launched a $10 billion debt-financed share buyback...

Markets & Companies

Pharma Players Mostly Lift 2015 Guidance

07.10.2015 - After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...

News

Bavarian Nordic Wins Janssen Ebola Subcontract

22.09.2015 - Bavarian Nordic, a Danish biotechnology company specializing in research, development and manufacture of active cancer immunotherapies and vaccines for infectious diseases, has...